Tobira Therapeutics, Inc.
CIK 0001311596
Revenue (TTM)
$832K
Q2 Aug 2016
Net Income (TTM)
−$58.76M
+57.7% YoY
Q2 Aug 2016
EPS Diluted (TTM)
—
Q2 Aug 2016
Gross Margin
—
Q2 Aug 2016
Operating Margin
-7,311.4%
Q2 Aug 2016
Net Margin
-7,062.7%
Q2 Aug 2016
Free Cash Flow (TTM)
−$52.71M
Q2 Aug 2016
Cash
$40.69M
Q2 Aug 2016
Total Debt
$15.25M
Q2 Aug 2016
Shares Outstanding
18.82M sh
Q2 Aug 2016
Revenue & Net Income
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.